The mNCP-SPI Score Predicting Risk of Severe COVID-19 among Mild-Pneumonia Patients on Admission
Open Access
- 1 October 2020
- journal article
- research article
- Published by Taylor & Francis in Infection and Drug Resistance
- Vol. ume 13, 3593-3600
Abstract
Purpose: To predict the risk of developing severe pneumonia among mild novel coronavirus pneumonia (mNCP) patients on admission. Methods: A retrospective cohort study was conducted at three hospitals in Shanghai and Wuhan from January 2020 to February 2020. Real-time polymerasechain–reaction assays were used to detect COVID-19. A total of 529 patients diagnosed with NCP were recruited from three hospitals and classified by four severity types during hospitalization following the standards of the Chinese Diagnosis and Treatment of Pneumonia Caused by New Coronavirus Infection (eighth version). Patients were excluded if admitted by ICU on admission (n=92, on a general ward while meeting the condition of severe or critical type on admission (n=25), or there was insufficient clinical information (n=64). In sum, 348 patients with mNCP were finally included, and 68 developed severe pneumonia. Results: mNCP severity prognostic index values were calculated based on multivariate logistic regression: history of diabetes (OR 2.064, 95% CI 1.010– 4.683; p=0.043), time from symptom onset to admission ≥ 7 days (OR 1.945, 95% CI 1.054– 3.587; p=0.033), lymphocyte count ≤ 0.8 (OR 1.816, 95% CI 1.008– 3.274; p=0.047), myoglobin ≥ 90 mg/L (OR 2.496, 95% CI 1.235– 5.047; p=0.011), and D-dimer ≥ 0.5 mg/L (OR 2.740, 95% CI 1.395– 5.380; p=0.003). This model showed a c-statistics of 0.747, with sensitivity and specificity 0.764 and 0.644, respectively, under cutoff of 165. Conclusion: We designed a clinical predictive tool for risk of severe pneumonia among mNCP patients to provided guidance for medicines. Further studies are required for external validation.Keywords
This publication has 33 references indexed in Scilit:
- Immunological mechanisms contributing to the double burden of diabetes and intracellular bacterial infectionsImmunology, 2015
- Factors associated with severe disease in hospitalized adults with pandemic (H1N1) 2009 in SpainClinical Microbiology and Infection, 2011
- Comparison of clinical characteristics and performance of pneumonia severity score and CURB-65 among younger adults, elderly and very old subjectsThorax, 2010
- Unmasking the Janus face of myoglobin in health and diseaseJournal of Experimental Biology, 2010
- Prevalence and Significance of Coagulation Abnormalities in Community-Acquired PneumoniaMolecular Medicine, 2009
- Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARSDiabetic Medicine, 2006
- Plasma d-Dimer Levels Correlate With Outcomes in Patients With Community-Acquired PneumoniaChest, 2004
- d-Dimer for the Exclusion of Acute Venous Thrombosis and Pulmonary EmbolismAnnals of Internal Medicine, 2004
- Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysisBMJ, 2003
- Coagulation, fibrinolysis, and fibrin deposition in acute lung injuryCritical Care Medicine, 2003